Armand Perret‐Liaudet

4.7k total citations
89 papers, 2.7k citations indexed

About

Armand Perret‐Liaudet is a scholar working on Molecular Biology, Physiology and Neurology. According to data from OpenAlex, Armand Perret‐Liaudet has authored 89 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 35 papers in Physiology and 29 papers in Neurology. Recurrent topics in Armand Perret‐Liaudet's work include Prion Diseases and Protein Misfolding (33 papers), Alzheimer's disease research and treatments (29 papers) and Dementia and Cognitive Impairment Research (17 papers). Armand Perret‐Liaudet is often cited by papers focused on Prion Diseases and Protein Misfolding (33 papers), Alzheimer's disease research and treatments (29 papers) and Dementia and Cognitive Impairment Research (17 papers). Armand Perret‐Liaudet collaborates with scholars based in France, Belgium and Germany. Armand Perret‐Liaudet's co-authors include Isabelle Quadrio, Sebastiaan Engelborghs, Kaj Blennow, Charlotte E. Teunissen, Lucilla Parnetti, José Luís Molinuevo, Piotr Lewczuk, Yannick Tholance, Nathalie Streichenberger and Anthony Fourier and has published in prestigious journals such as Nature Medicine, Nature Communications and PLoS ONE.

In The Last Decade

Armand Perret‐Liaudet

86 papers receiving 2.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Armand Perret‐Liaudet France 28 1.2k 1.1k 771 735 639 89 2.7k
Marcello Rossi Italy 31 1.0k 0.9× 658 0.6× 318 0.4× 1.1k 1.5× 530 0.8× 78 2.7k
Anja Hviid Simonsen Denmark 28 749 0.6× 1.0k 1.0× 683 0.9× 459 0.6× 296 0.5× 104 2.4k
Masaki Takao Japan 28 1.4k 1.1× 600 0.6× 287 0.4× 998 1.4× 595 0.9× 160 3.1k
Kina Höglund Sweden 29 743 0.6× 1.4k 1.3× 686 0.9× 606 0.8× 456 0.7× 68 2.5k
Henrik Zetterberg Sweden 28 640 0.5× 1.1k 1.0× 753 1.0× 602 0.8× 418 0.7× 172 2.5k
Kensuke Sasaki Japan 22 835 0.7× 727 0.7× 358 0.5× 280 0.4× 462 0.7× 69 2.0k
Amanda Heslegrave United Kingdom 41 1.3k 1.1× 1.6k 1.5× 751 1.0× 1.2k 1.6× 996 1.6× 139 4.3k
Mikko Hölttä Sweden 14 979 0.8× 1.1k 1.0× 619 0.8× 281 0.4× 343 0.5× 21 2.3k
Juan Manuel Maler Germany 25 742 0.6× 1.5k 1.4× 851 1.1× 258 0.4× 514 0.8× 59 2.3k
Christoffer Rosén Sweden 13 741 0.6× 1.4k 1.3× 975 1.3× 433 0.6× 485 0.8× 14 2.4k

Countries citing papers authored by Armand Perret‐Liaudet

Since Specialization
Citations

This map shows the geographic impact of Armand Perret‐Liaudet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armand Perret‐Liaudet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armand Perret‐Liaudet more than expected).

Fields of papers citing papers by Armand Perret‐Liaudet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armand Perret‐Liaudet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armand Perret‐Liaudet. The network helps show where Armand Perret‐Liaudet may publish in the future.

Co-authorship network of co-authors of Armand Perret‐Liaudet

This figure shows the co-authorship network connecting the top 25 collaborators of Armand Perret‐Liaudet. A scholar is included among the top collaborators of Armand Perret‐Liaudet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armand Perret‐Liaudet. Armand Perret‐Liaudet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Verdurand, Mathieu, Sophie Lancelot, Waël Zeinyeh, et al.. (2018). Amyloid-Beta Radiotracer [18F]BF-227 Does Not Bind to Cytoplasmic Glial Inclusions of Postmortem Multiple System Atrophy Brain Tissue. Contrast Media & Molecular Imaging. 2018. 1–7. 16 indexed citations
3.
Sauzéat, Lucie, E Bernard, Armand Perret‐Liaudet, et al.. (2018). Isotopic Evidence for Disrupted Copper Metabolism in Amyotrophic Lateral Sclerosis. iScience. 6. 264–271. 46 indexed citations
4.
Chapuis, Jérôme, Mohammed Moudjou, Fabienne Reine, et al.. (2016). Emergence of two prion subtypes in ovine PrP transgenic mice infected with human MM2-cortical Creutzfeldt-Jakob disease prions. Acta Neuropathologica Communications. 4(1). 10–10. 27 indexed citations
5.
Tholance, Yannick, Gleicy Keli Barcelos, Armand Perret‐Liaudet, et al.. (2016). Placing intracerebral probes to optimise detection of delayed cerebral ischemia and allow for the prediction of patient outcome in aneurysmal subarachnoid haemorrhage. Journal of Cerebral Blood Flow & Metabolism. 37(8). 2820–2832. 12 indexed citations
6.
Dorey, Aline, Armand Perret‐Liaudet, Yannick Tholance, Anthony Fourier, & Isabelle Quadrio. (2015). Cerebrospinal Fluid Aβ40 Improves the Interpretation of Aβ42 Concentration for Diagnosing Alzheimer’s Disease. Frontiers in Neurology. 6. 247–247. 51 indexed citations
7.
Dorey, Aline, Yannick Tholance, Alain Vighetto, et al.. (2015). Association of Cerebrospinal Fluid Prion Protein Levels and the Distinction Between Alzheimer Disease and Creutzfeldt-Jakob Disease. JAMA Neurology. 72(3). 267–267. 55 indexed citations
8.
Kovács, Gábor G., Uta Wagner, Benoît Dumont, et al.. (2012). An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology. Acta Neuropathologica. 124(1). 37–50. 124 indexed citations
9.
Vanderstichele, Hugo, Mirko Bibl, Sebastiaan Engelborghs, et al.. (2011). Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: A consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimer s & Dementia. 8(1). 65–73. 238 indexed citations
10.
Quadrio, Isabelle, Armand Perret‐Liaudet, & Gábor G. Kovács. (2011). Molecular diagnosis of human prion disease. Expert Opinion on Medical Diagnostics. 5(4). 291–306. 7 indexed citations
11.
Gabelle, Audrey, Stéphane Roche, Christian Gény, et al.. (2010). Correlations between soluble α/β forms of amyloid precursor protein and Aβ38, 40, and 42 in human cerebrospinal fluid. Brain Research. 1357. 175–183. 54 indexed citations
12.
Perret‐Liaudet, Armand, et al.. (2010). Apport diagnostic des marqueurs biologiques de la maladie d’Alzheimer (MA) dans une observation de dégénérescence lobaire fronto-temporale (DLFT). Revue Neurologique. 167(2). 160–163. 1 indexed citations
13.
Séronie-Vivien, Sophie, Marie‐Madeleine Galteau, Marie-Christine Carlier, et al.. (2005). Impact of standardized calibration on the inter-assay variation of 14 automated assays for the measurement of creatinine in human serum. Clinical Chemistry and Laboratory Medicine (CCLM). 43(11). 1227–33. 25 indexed citations
14.
Favereaux, Alexandre, Isabelle Quadrio, C Vital, et al.. (2004). Pathologic Prion Protein Spreading in the Peripheral Nervous System of a Patient With Sporadic Creutzfeldt-Jakob Disease. Archives of Neurology. 61(5). 747–747. 15 indexed citations
15.
Biacabé, Anne-Gaëlle, Nathalie Streichenberger, James W. Ironside, et al.. (2003). Immunohistochemical localization of 14.3.3 ζ protein in amyloid plaques in human spongiform encephalopathies. Acta Neuropathologica. 105(3). 296–302. 31 indexed citations
16.
Mertens, Patrick, Lionel Bert, Armand Perret‐Liaudet, et al.. (2001). Microdialysis study of amino acid neurotransmitters in the spinal dorsal horn of patients undergoing microsurgical dorsal root entry zone lesioning. Journal of Neurosurgery Spine. 94(1). 165–173. 13 indexed citations
17.
Lézin, Agnès, Stéphanie Buart, Didier Smadja, et al.. (2000). Tissue Inhibitor of Metalloproteinase 3, Matrix Metalloproteinase 9, and Neopterin in the Cerebrospinal Fluid: Preferential Presence in HTLV Type I-Infected Neurologic Patients versus Healthy Virus Carriers. AIDS Research and Human Retroviruses. 16(10). 965–972. 25 indexed citations
18.
Mertens, Patrick, et al.. (2000). Amino acids in spinal dorsal horn of patients during surgery for neuropathic pain or spasticity. Neuroreport. 11(8). 1795–1798. 19 indexed citations
19.
Bellier, Jean‐Pierre, et al.. (2000). Glutamic Acid Decarboxylase‐Expressing Astrocytes Exhibit Enhanced Energetic Metabolism and Increase PC12 Cell Survival Under Glucose Deprivation. Journal of Neurochemistry. 75(1). 56–64. 9 indexed citations
20.
Artru, F, et al.. (1998). Low brain tissue oxygen pressure: Incidence and corrective therapies. Neurological Research. 20(sup1). S48–S51. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marcello Rossi Breakdown of academic impact, for papers by Anja Hviid Simonsen Breakdown of academic impact, for papers by Masaki Takao Breakdown of academic impact, for papers by Kina Höglund Breakdown of academic impact, for papers by Henrik Zetterberg Breakdown of academic impact, for papers by Kensuke Sasaki Breakdown of academic impact, for papers by Amanda Heslegrave Breakdown of academic impact, for papers by Mikko Hölttä Breakdown of academic impact, for papers by Juan Manuel Maler Breakdown of academic impact, for papers by Christoffer Rosén
Rankless by CCL
2026